Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-FU vs MTX+5-FU in Gastric Cancer With Peritoneal Metastasis
NCT00149201Phase 3Completed
- Sponsor
- Japan Clinical Oncology Group
- Start
- Nov 2002
- Primary completion
- Apr 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methotrexate in gastric adenocarcinoma, sponsored by Japan Clinical Oncology Group. Started Nov 2002; status: completed.
02
Drugs
methotrexate
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT00149201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00149201.